ESOT The European Society
for Organ Transplantation

What can we help you find?

Leading the way in transplantation

Filter results for:

Don't need the search bar? Close it here

ECP Immunomodulation Award in Solid Organ Transplantation – 2025 edition

February 28, 2025 | All

Supported by Therakos, the award offers a EUR 50,000 educational grant to recognise and support the institution of those individuals making a difference in advancing the knowledge around Therakos ECP* Immunomodulation in Solid Organ Transplantation.

This year’s award programme invites applications of projects that are expected to impact the clinical practice of Solid Organ Transplant patients and investigate the overarching immunomodulatory role of Therakos ECP* in Solid Organ Transplantation.

Specifically, the grant will support studies using the Therakos fully integrated and validated ECP* system, that will evaluate the basic and translational science of ECP* used in the treatment pathway, particularly focusing on:

  • Early use of ECP* immunomodulation to improve patient outcomes (i.e., graft survival and HRQoL) in Solid Organ Transplant patients
  • ECP* immunomodulation to prevent chronic rejection
  • Biomarkers of treatment response to ECP* in Solid Organ transplant rejection
  • use of ECP* immunomodulation in high risk, frail patients with comorbidities.

The award represents a unique opportunity for transplant professionals to support their development as researchers by fostering the exchange of knowledge, longer-term collaborations, and establishing personal, scientific, and corporate links between sectors.

The institution of the successful applicant will be awarded the EUR 50,000 grant, to be used in a specified timeframe of 12 months for a defined research project described within the application.

The key dates are:

  1. Application period: 1 March 2025 – 28 April 2025
  2. Notifications: 27 May 2025

ESOT would like to thank Therakos for making this opportunity feasible.


Conditions to apply:

  • Candidates must be ESOT members in good standing at the time of the application to validate the application submission; applications from non ESOT members will not be considered. To purchase or renew the ESOT membership, please visit this page.
  • Applicants must hold a PhD and /or a MD degree.
  • Applicants must provide a detailed outline of their research plans for the grant funding.
  • Applicants are required to use Therakos ECP* systems.
  • No more than one application per applicant will be considered.
  • No restriction on the applicant’s age and nationality applies.
  • Applicants should have clinical research experience as an investigator or co-investigator at the beginning of their career.
  • Previously ESOT funded applicants are also eligible for this programme.

 

Application process:

  • Applications are submitted in English by email to denise.desalvo@esot.org by Monday, 28 April at 23:59 CEST.
  • Applicants must submit the following information: first name, family name, institution, city, country, email address, title of the research project.
  • Applicants must attach the following documents: research project (max. 3 pages), CV (max. 2 pages).
  • To process applications, ESOT must process the applicant’s personal data as provided in the application submission. The applicant gives his/her consent to such control and processing of the applicant’s personal data.

 

Review process:

  • Applications are reviewed by a selection committee composed of 2 ESOT Executive Committee members and 2 external experts nominated by the ESOT Executive Committee.
  • Reviewers are requested to score each application in 3 domains based on the candidate’s profile and the submitted research project. The application with the best average score will be awarded.
  • The awardee will be invited to attend the ESOT Congress 2025 where he/she will be announced and celebrated. The completed project will be presented at the next ESOT Congress in 2027.
  • The primary criteria that the Selection Committee will evaluate will be the following:
    • the track record of the applicant (25%)
    • the added value of the fellowship to the individual’s career development (25%)
    • the innovation and potential impact of the applicant’s research on improved transplantation outcomes (50%).

The full Terms of Reference document is available here.

Should you have any queries regarding this award, please contact Ms. Denise De Salvo at denise.desalvo@esot.org.

*Extracorporeal Photopheresis

Share this